Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE study.

Paolo ColonnaChristian von HeymannAmparo SantamariaManish SaxenaThomas VanasscheDiana WolpertPetra LaeisRobert WilkinsCathy ChenMartin Unverdorben

Published in: Clinical cardiology (2020)

The periprocedural bleeding and acute thromboembolic event risks for patients treated with edoxaban were low. This can help inform both clinical routine and guidelines for the periprocedural management of edoxaban.

Keyphrases

clinical practice
venous thromboembolism
direct oral anticoagulants
atrial fibrillation
catheter ablation
percutaneous coronary intervention
liver failure
risk factors
acute coronary syndrome
cross sectional
respiratory failure
mesenchymal stem cells
intensive care unit
hepatitis b virus
climate change